Dermal rejuvenation compositions and methods

Abstract

The present invention relates, e.g., to a system for treating damaged skin, comprising a cosmeceutical formulation comprising about 1-10% of a mixture of perfluorocarbons (PFC's) of at least three different molecular weights, and about 0.001-5% hyaluronic acid (HA) of molecular weight about 100 kDa or less, packaged in an aerosol spray container.

We claim: 
     
         1 . A system for treating damaged skin, comprising a cosmeceutical formulation which comprises:
 about 1-10% of a mixture of perfluorocarbons (PFC's) of at least three different molecular weights and   about 0.001-5% hyaluronic acid (HA) of molecular weight about 100 kDa or less,   packaged in an aerosol spray hand-held container.   
     
     
         2 . The system of  claim 1 , wherein the cosmeceutical formulation is aqueous. 
     
     
         3 . The system of  claim 1 , wherein the cosmeceutical formulation comprises an oil and water emulsion. 
     
     
         4 . The system of  claim 1 , wherein the mixture of PFC's comprises perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, perfluorodecalin, perfluorodimethyl-cyclohexane, perfluoroperhydrophenanthrene, pentafluoropropane, perfluorotripropylamine, C 6 -C 9  perfluoroalkanes, perfluoroperhydrofluoranthrene, perfluorodecalin, perfluoroperhydro-phenanthrene, bis(perfluor-hexyl)-1,2-ethene, perfluoro-1,3-dimethylcyclohexane, perfluoro-methyldecalin, perfluoroisopropyldecalin, a mixture of perfluorodixylylmethane and perfluorodixylylethane, and/or a mixture of perfluoroperhydrophenanthrene and perfluoro n-butyl decalin. 
     
     
         5 . A method for treating damaged skin, comprising administering with an aerosol spray hand-held container a cosmeceutical formulation comprising
 about 1-10% of a mixture of perfluorocarbons of at least three different molecular weights, and   about 0.001-5.0% hyaluronic acid of molecular weight about 100 kDa or less.   
     
     
         6 . The method of  claim 5 , wherein the cosmeceutical formulation comprises an oil and water emulsion. 
     
     
         7 . The method of  claim 5 , comprising about 10% perfluorocarbons. 
     
     
         8 . The method of  claim 5 , which is effective for aiding in wound healing, treating sunburn or acne lesions, treating damage resulting from chemical peels, increasing skin moisturization, and/or reducing fine lines and wrinkles. 
     
     
         9 . The system of  claim 1 , wherein the cosmeceutical formulation further comprises one or more of niacin or other vitamins, minerals, enzymes, amino acids, antioxidants, blood dilating ingredients, or natural enjoyable fragrances. 
     
     
         10 . The system of  claim 1 , wherein the cosmeceutical formulation further comprises HSC (Hydrophobic Sphingolipid Complex), Atoxelene; and a light, natural fragrance. 
     
     
         11 . The system of  claim 1 , wherein the cosmeceutical formulation further comprises one or more of: an intracellular oxygen booster (0.005-30%); emulsifiers, (0.1-20%); rheology modifiers, (0.05-5%); humectants (0.5-8%); surfactants (0.1-5%); emollients (0.1-20%); pH modifiers (0.005-2%); antimicrobial agents (0.001-3%); colorants (0.001-30%); aromas (0.005-5%); or antioxidants (0.005-5%). 
     
     
         12 . The system of  claim 11 , wherein the intracellular oxygen booster is  Tropaeolum Majus  Flower/Leaf/Stem Extract; the emulsifier is a nonionic, cationic, anionic or polymeric emulsifier; the rheology modifier is a polyacrylic acid polymer, xanthan gum, cellulose gum, silicate, alginate, or hydrocolloid; the humectant is propanediol, glycerin or another glycol; the surfactant is cationic, anionic, ethoxylated or non-ethoxylated; the antimicrobial agent is salicylic acid or a preservative; the colorant is an FD&C color, iron oxide, or titanium dioxide; the aroma is in the form of a fragrance or essential oil; and the antioxidant is ascorbic acid. 
     
     
         13 . The system of  claim 1 , wherein the formulation is for treatment of adult acne, and the formulation further comprises salicylic acid. 
     
     
         14 . The system of  claim 1 , wherein the formulation is for treatment of cellulite, and the formulation further comprises adipogenesis inhibitors, lipogenesis inhibitors, and/or or lipolytic agents. 
     
     
         15 . The system of  claim 1 , wherein the formulation is for use as a foundation for make-up, and the formulation further comprises one or more suitable colorants. 
     
     
         16 . The system of  claim 1 , wherein the molecular weight of the HA is less than or about 50 kDa. 
     
     
         17 . The system of  claim 1 , wherein the HA is in an amount of about 0.1%. 
     
     
         18 . The system of  claim 1 , wherein the formulation is partially saturated, saturated, or supersaturated with oxygen. 
     
     
         19 . An aerosol container comprising, under pressure, a cosmeceutical formulation comprising
 about 1-10% of a mixture of perfluorocarbons (PFC's) of at least three different molecular weights and   about 0.001-5% hyaluronic acid (HA) of molecular weight about 100 kDa or less.   
     
     
         20 . The aerosol container of  claim 20 , wherein the cosmeceutical formulation comprises an oil and water emulsion.